New Features in Screening of Retinopathy of Prematurity. Our Experience with New Recommendations for Retinopathy of Prematurity Screening
New Features in Screening of Retinopathy of Prematurity. Our Experience with New Recommendations for Retinopathy of Prematurity Screening
Retinopathy of prematurity (ROP) is always a serious and sight-threatening condition, and its treatable stages require early detection and adequate treatment. It is necessary to focus on the principles of screening of ROP and recurrences thereof, which occur more often with the onset of intravitreal treatment using anti-vascular endothelial growth factor (anti-VEGF) agents. In this study, we evaluate the recurrence of ROP after primary treatment with intravitreally administered bevacizumab or ranibizumab, its frequency and timing of occurrence. Also discussed are the rules for screening of ROP, its recurrence and the need for long-term follow-up monitoring of children with any form of ROP.
Keywords:
recurrence of ROP – ROP recurrence screening – intravitreal treatment of ROP – follow-up monitoring of premature infants with ROP – ROP screening
Autoři:
Dana Tomčíková; Zuzana Prepiaková; Beáta Bušányová; Barbora Kostolná
Působiště autorů:
University and the National Institute of Children’s Diseases, Bratislava, Slovakia
; Department of Pediatric Ophthalmology, Faculty of Medicine of Comenius
Vyšlo v časopise:
Čes. a slov. Oftal., 81, 2025, No. Ahead of Print, p. 1-5
Kategorie:
Původní práce
doi:
https://doi.org/10.31348/2025/23
Souhrn
Retinopathy of prematurity (ROP) is always a serious and sight-threatening condition, and its treatable stages require early detection and adequate treatment. It is necessary to focus on the principles of screening of ROP and recurrences thereof, which occur more often with the onset of intravitreal treatment using anti-vascular endothelial growth factor (anti-VEGF) agents. In this study, we evaluate the recurrence of ROP after primary treatment with intravitreally administered bevacizumab or ranibizumab, its frequency and timing of occurrence. Also discussed are the rules for screening of ROP, its recurrence and the need for long-term follow-up monitoring of children with any form of ROP.
Štítky
OftalmologieČlánek vyšel v časopise
Česká a slovenská oftalmologie
2025 Číslo Ahead of Print
- Diagnostický algoritmus při podezření na syndrom periodické horečky
- Stillova choroba: vzácné a závažné systémové onemocnění
- Kontaktní dermatitida očních víček
- Pseudoxanthoma elasticum − vzácné onemocnění s dosud limitovanými možnostmi léčby
- Léčba chronické blefaritidy vyžaduje dlouhodobou péči
Nejčtenější v tomto čísle
- Clinical Outcomes of Preserflo MicroShunt versus Trabeculectomy: A Retrospective 6-Month Study
- Choroidal Neovascular Membrane in Pediatric Patients: Long-Term Outcomes of Anti-VEGF Therapy
- Idiopathic Corneal Thinning and Spontaneous Perforation at Early Adulthood. A Case Report
- Tear Film Dysfunction and its Association with Smartphone Usage in Adolescents